Table 4.
Clinical Outcomes for Diabetic Patients in PDCM and HPDCM Groups
| Outreached* | Number of measurements (individuals) | PDCM | HPDCM | Difference in Differences [(B)–(A)] –[(D)–(C)] (95 % CI) | ||||
|---|---|---|---|---|---|---|---|---|
| 12-month Before (A) | 12-month After (B) | Difference (B)–(A) (95 % CI) | 12-month Before (C) | 12-month After (D) | Difference (D)–(C) (95 % CI) | |||
| Prop. A1c < 7 % | 8,036 | 0.47 | 0.46 | −0.01 | 0.43 | 0.43 | 0.003 | −0.01 |
| (2,312) | (−0.04, 0.02) | (−0.03, 0.04) | (−0.06, 0.03) | |||||
| Prop.Optimal outcome§ | 3,742 | 0.14 | 0.18 | 0.04 | 0.09 | 0.12 | 0.03 | 0.01 |
| (1,472) | (−0.002, 0.09) | (0.02, 0.06) | (−0.04, 0.06) | |||||
| Prop. SBP < 140 mmHg & DBP < 80 mmHg | 11,982 | 0.60 | 0.61 | 0.01 | 0.44 | 0.47 | 0.03 | −0.02 |
| (2,332) | (−0.02, 0.04) | (−0.001, 0.06) | (−0.06, 0.02) | |||||
| Prop. LDL < 100 mg/dL | 7,277 | 0.61 | 0.65 | 0.04 | 0.57 | 0.59 | 0.02 | 0.02 |
| (2,477) | (0.01, 0.07) | (−0.01, 0.06) | (−0.03, 0.06) | |||||
| Prop.HDL ≥ 40 mg/dL (male) and 50 mg/dL(female) | 7,164 | 0.39 | 0.39 | −0.005 | 0.44 | 0.48 | 0.04 | −0.04 |
| (2,455) | (−0.03, 0.03) | (0.01, 0.07) | (−0.03, 0.03) | |||||
| Prop. total cholesterol ≤ 200 mg/dL | 6,506 | 0.79 | 0.80 | 0.01 | 0.74 | 0.77 | 0.03 | −0.02 |
| (2,452) | (−0.02, 0.03) | (−0.01, 0.06) | (−0.06, 0.02) | |||||
| Mean Weight in kg | 11,809 | 101.2 | 102.1 | 0.87 | 103.8 | 102.9 | −0.84 | 1.71 |
| (2,310) | (−0.46, 1.89) | (−2.22, 0.43) | (−0.68, 3.48) | |||||
| Prop. obese | 9,493 | 0.71 | 0.72 | 0.02 | 0.75 | 0.72 | −0.03 | 0.04 |
| (2,177) | (−0.01, 0.04) | (−0.06, −0.003) | (0.003,0.08) | |||||
| Prop. extreme obese | 9,493 | 0.21 | 0.23 | 0.03 | 0.24 | 0.25 | 0.01 | 0.02 |
| (2,177) | (0.004, 0.05) | (−0.03, 0.04) | (−0.02,0.06) | |||||
| Engaged † | ||||||||
| Prop. A1c < 7 % | 2,792 | 0.42 | 0.42 | 0.003 | 0.43 | 0.47 | 0.04 | −0.04 |
| (706) | (−0.03, 0.04) | (−0.04, 0.12) | (−0.12, 0.06) | |||||
| Prop.Optimal outcome‡ | 1,225 | 0.16 | 0.16 | 0.004 | 0.07 | 0.17 | 0.10 | −0.09 |
| (498) | (−0.05, 0.08) | (−0.01, 0.18) | (−0.19, 0.05) | |||||
| Prop. SBP < 140 mmHg & DBP < 80 | 3,879 | 0.59 | 0.59 | 0.001 | 0.44 | 0.51 | 0.07 | −0.07 |
| (738) | (−0.05, 0.05) | (−0.01, 0.16) | (−0.17, 0.02) | |||||
| Prop. LDL < 100 mg/dL | 2,163 | 0.64 | 0.67 | 0.04 | 0.48 | 0.59 | 0.12 | −0.08 |
| (740) | (−0.01, 0.08) | (0.001,0.23) | (−0.21, 0.05) | |||||
| Prop.HDL ≥ 40 mg/dL (male) and 50 mg/dL(female) | 2,213 | 0.37 | 0.35 | −0.02 | 0.38 | 0.44 | 0.06 | −0.09 |
| (726) | (−0.05, 0.02) | (−0.04, 0.17) | (−0.19, 0.02) | |||||
| Prop. total cholesterol ≤ 200 mg/dL | 2,034 | 0.78 | 0.81 | 0.02 | 0.76 | 0.84 | 0.08 | −0.06 |
| (726) | (−0.01, 0.06) | (−0.003, 0.18) | (−0.17, 0.03) | |||||
| Mean Weight in kg | 3,854 | 104.9 | 106.1 | 1.20 | 112.3 | 108.9 | −3.45 | 4.65 |
| (737) | (−0.91, 3.02) | (−8.82, 0.72) | (−0.02, 10.10) | |||||
| Prop. obese | 3,045 | 0.79 | 0.79 | −0.002 | 0.82 | 0.76 | −0.05 | 0.05 |
| (704) | (−0.03, 0.02) | (−0.14, −0.03) | (−0.03, 0.14) | |||||
| Prop. extreme obese | 3,045 | 0.28 | 0.29 | 0.01 | 0.36 | 0.34 | −0.02 | 0.03 |
| (704) | (−0.04, 0.05) | (−0.14, 0.06) | (−0.07, 0.14) | |||||
See footnotes under Tables 2 and 3
* Outreached patients were those who received an attempted or actual contact for enrollment in care management
† Engaged patients were those who had one or more care management sessions/encounters with a care manager
‡ Optimal outcome = A1c < 7 %, SBP < 140 mmHg, DBP < 90 mmHg, and LDL < 100 mg/dL